Oral antibiotic prophylaxis for infection in patients with vascular anomalies receiving sirolimus treatment: a multicenter retrospective study

OBJECTIVES: Patients with vascular anomalies (VAs) who receive oral sirolimus may be at high risk of infectious complications. Antibiotic prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMZ) has been advocated. However, there have been few evidence-based analyses on this topic. This study assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Tong, Li, Yanan, Gong, Xue, Zhou, Jiangyuan, Yang, Kaiying, Zhang, Xuepeng, Zhang, Zixin, Lan, Yuru, Hu, Fan, Peng, Qiang, Zhang, Yongbo, Kong, Feiteng, Chen, Siyuan, Ji, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207744/
https://www.ncbi.nlm.nih.gov/pubmed/37221564
http://dx.doi.org/10.1186/s13023-023-02740-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207744/
https://www.ncbi.nlm.nih.gov/pubmed/37221564
http://dx.doi.org/10.1186/s13023-023-02740-3

Ejemplares similares